Arrhythmias & electrophysiology

Efficacy of fludrocortisone for symptom relief in patients with autonomic syncope and hypotensive phenotype

EuropacePublished Multicentre, prospective, non-randomized study

Authors' conclusion

Fludrocortisone therapy was associated with reduced hypotension and the burden of symptoms both in younger and in older patients. Side effects lead to discontinuation of therapy in 17% of cases.

Study context

Population
Patients with autonomic syncope and hypotensive phenotypeCohort treated with fludrocortisone (median age 38 [IQR 21–57]) years, 83% females), a total of 83 patients were analysed · Younger (23 ± 6 yrs), analysed 42 · Older (56 ± 12 yrs), analysed 41
Participants
94 patients
Comparison
Before therapy vs during follow-up on fludrocortisone therapy; Ambulatory blood pressure monitoring (ABPM) 1 (before treatment start) vs ABPM 2 (after drug optimization)
  • Fludrocortisone therapyn = 94
Primary endpoint
Reduction of the syncope burden and presyncopal symptoms based on validated semi structured questionnaires
Follow-up
Median 12.9 months

Primary result

As reported in the abstract

Reduction in annual syncope burden

50.2%

P = 0.0001

By group

Subjective symptom improvement reported by
85.6% of patients
The frequency of syncope/presyncope decreased significantly
P = 0.009

Secondary outcomes

OutcomeABPM 1ABPM 2Decrease in number of daytime SBP dropsP value
Average 24-hour systolic blood pressure (SBP)Increased from ABPM 1 to ABPM 2106.3 ± 8.2 mmHg112.3 ± 9.3P = 0.0001
Secondary endpoint: hypotensive episodes on ABPM (number of daytime SBP drops)SBP drops <90 mmHg61%P < 0.001 for both
Secondary endpoint: hypotensive episodes on ABPM (number of daytime SBP drops)SBP drops <100 mmHg45%P < 0.001 for both

Outcome by age (subgroup)

The outcome was similar in 42 younger (23 ± 6 yrs) and in 41 older (56 ± 12 yrs) patients

Safety

Patients who stopped therapy due to side effects
16 patients
Occurring during optimization
#11
Occurring during follow-up
#5

Original publication

Efficacy of fludrocortisone for symptom relief in patients with autonomic syncope and hypotensive phenotype. Europace. Published 3 November 2026. doi:10.1093/europace/euag304

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.